| Code | Description | Claims | Beneficiaries | Total Paid |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,209 |
13,357 |
$644K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
8,245 |
7,703 |
$542K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,400 |
6,993 |
$528K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,247 |
11,020 |
$523K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,524 |
3,322 |
$246K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,370 |
6,874 |
$209K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,230 |
2,097 |
$173K |
| 99381 |
|
992 |
893 |
$73K |
| 99460 |
|
859 |
790 |
$46K |
| 99173 |
|
7,801 |
7,320 |
$43K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
773 |
712 |
$40K |
| 36415 |
Collection of venous blood by venipuncture |
13,912 |
12,950 |
$30K |
| 92551 |
|
3,930 |
3,653 |
$29K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,652 |
2,466 |
$17K |
| 17250 |
|
306 |
273 |
$13K |
| 90651 |
|
1,342 |
1,253 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
120 |
114 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
933 |
731 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
788 |
322 |
$7K |
| 90670 |
|
5,358 |
5,095 |
$5K |
| 99383 |
|
51 |
45 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
240 |
220 |
$4K |
| 90734 |
|
1,015 |
941 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
102 |
84 |
$2K |
| 90620 |
|
295 |
278 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
28 |
28 |
$2K |
| 90710 |
|
659 |
626 |
$2K |
| 90723 |
|
4,394 |
4,168 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
60 |
60 |
$1K |
| 36416 |
|
729 |
637 |
$1K |
| 90681 |
|
2,911 |
2,776 |
$960.03 |
| 90716 |
|
1,972 |
1,832 |
$866.80 |
| 96127 |
|
213 |
210 |
$864.06 |
| 90633 |
|
2,952 |
2,791 |
$635.50 |
| 90715 |
|
244 |
222 |
$540.75 |
| 87807 |
|
49 |
46 |
$518.80 |
| 90696 |
|
741 |
699 |
$518.12 |
| 90647 |
|
5,956 |
5,641 |
$487.29 |
| 90707 |
|
1,686 |
1,560 |
$391.61 |
| 90700 |
|
1,356 |
1,285 |
$280.00 |
| 90688 |
|
269 |
251 |
$62.55 |
| 90744 |
|
386 |
369 |
$26.69 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
225 |
206 |
$10.52 |
| 94760 |
|
15 |
15 |
$5.55 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
46 |
33 |
$0.30 |
| 90677 |
|
1,137 |
1,049 |
$0.24 |
| 90649 |
|
176 |
156 |
$0.00 |
| 90671 |
|
186 |
180 |
$0.00 |
| 99000 |
|
8,440 |
7,676 |
$0.00 |
| 90697 |
|
159 |
157 |
$0.00 |
| 90698 |
|
443 |
422 |
$0.00 |
| 99058 |
|
592 |
533 |
$0.00 |
| 90686 |
|
226 |
219 |
$0.00 |
| 3008F |
|
32 |
32 |
$0.00 |